HTT and Huntington disease: Approach toward targeting the mHTT gene in allele‐specific manner, since HD patients typically have one normal (wild‐type) and one mutant allele of the HTT gene, it is possible to design CRISPR/Cas9 strategies that selectively target the abnormal allele while preserving expression of wild‐type protein.408